Danaher Corporation (DHR)
A forensic read on Danaher Corporation built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.
Danaher Corporation manufactures and markets industrial instruments for measurement, display, and control, serving diverse markets globally with a focus on life sciences and diagnostics. Revenue increased to $24.57B in FY2025 from $23.88B in FY2024, while net margin compressed from 16.3% to 14.7% over the same period.
The forensic grade and screens above are free — no account needed. Want the AI investment read on top — the 0–100 rating, thesis, bull-vs-bear, red flags and the 12-month scenario, written from Danaher Corporation's actual 10-K/10-Q/8-K filings?
Generate the AI investment read →No credit card · informational only, not investment advice · see the track record
← Browse all forensic stock analyses
Data from SEC EDGAR public filings · metrics as of Sep 22, 2026. Forensic signals flag probability, not certainty.